EU Clears Total's Purchase of Polimeri Unit

European antitrust authorities approved the acquisition on Thursday of parts of Polimeri Europa Benelux, a chemicals group, by Total Petrochemicals Feluy, a division of French energy group Total. Polimeri Europa Benelux, which is ultimately controlled by Italian energy company Eni, makes specialty chemicals and commodity polymers.

Total Petrochemicals also makes commodity polymers, but the European Commission said the acquisition would not harm competition.

"The Commission's investigation showed that the transaction would lead to a relatively small overlap and the combined entity would continue to face several competitors," it said in a statement.

The transaction concerns Total Petrochemicals acquisition of Polimeri's polystyrene production lines and related polystyrene business in Feluy, Belgium. Polysytrene is used in packaging, consumer goods and electrical and electronic appliances.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.